Naoki Okamura
Pharma

Astellas CEO resists 'rescue BD' as Xtandi patent cliff nears

With Xtandi set to lose U.S. patent protection next year, Astellas’ CEO fielded questions this week about his company’s BD strategy ahead of the loss.
Angus Liu Jan 15, 2026 10:42am
FDA

FDA proposes flu shot labels include warnings for febrile seizures

Jan 15, 2026 12:07pm
President Trump speaks in the Oval Office
Favicon Fierce Healthcare

Trump targets insurers, drug prices in 'Great Healthcare Plan'

Jan 15, 2026 11:51am
BeOne Medicines Brukinsa TV ad

FDA chides BeOne, ImmunityBio in separate untitled letters

Jan 15, 2026 11:50am
John JJson Johnson

Johnson & Johnson's Tecvayli struts its stuff as a monotherapy

Jan 15, 2026 10:15am
A triptych featuring images of Erica Wheeler in basketball jerseys with PAP and HPV and a close up of her socks with the

Hologic sets a screen to block cervical cancer with WNBA star

Jan 15, 2026 10:00am
More News

JPM26: Jazz inks $200M priority review voucher sale

Jan 14, 2026 3:55pm

Bayer taps Gabrielle Union-Wade as face of menopause med Lynkuet

Jan 14, 2026 3:30pm

JPM26, Day 3: AbbVie, AZ, Novo execs share visions for ’26

Jan 14, 2026 2:29pm
Fierce Biotech

JPM26: Sanofi looks ahead to lingering US policy hurdles

Jan 14, 2026 2:28pm